MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202647096815 A) filed by Innovent Biologics Suzhou Co. , Ltd. on August 11, 2026, for Anti-Cd28 Antibody And Use Thereof.
Inventors include Xiong, Huizhong; Zhang, Xiguang; Li, Li; and Zhou, Shuaixiang.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: An antibody or an antigen-binding fragment thereof. The antibody or the antigen-binding fragment thereof can specifically bind to a CD28 protein, such as human CD28 protein. Also provided is a multispecific binding molecule, such as a multispecific antibody, that specifically binds to CD28 and one or more tumor-associated antigens. Further provided are a nucleic acid molecule encoding the antibody, an expression vector for expressing the antibody, a host cell and a preparation method therefor. Also provided are methods of diagnosis and treatment using the antibody.
Disclaimer: Curated by HT Syndication.
